Jianmeng Zhu, Hongqin Wang, Kaiqiang Li, Xiuze Yuan, Wenzhong Hong
{"title":"Black Phosphorus Nanosheets-Loaded Single-Atom Gold Nanoenzymes for Enhanced Photodynamic Therapy of Hepatocellular Carcinoma.","authors":"Jianmeng Zhu, Hongqin Wang, Kaiqiang Li, Xiuze Yuan, Wenzhong Hong","doi":"10.2147/IJN.S414938","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Conventional treatments for hepatocellular carcinoma (HCC) lack efficacy and targeting abilities. Photodynamic therapy (PDT) has emerged as a promising alternative for targeted and minimally invasive tumor treatments. However, many biomaterials used in PDT pose biosafety concerns and insufficient enzyme activity often leads to limited reactive oxygen species (ROS) production, resulting in poor PDT efficacy. Single-atom nanoenzymes have attracted much research attention as a novel type of high-performance nanoenzymes.</p><p><strong>Methods: </strong>In this study, we prepared black phosphorus nanosheets (BP) with good biocompatibility as a platform and loaded single-atom gold nanoenzymes onto BP nanosheets to treat HCC. To enhance the stability and targeting ability of the nanohybrid, it was PEGylated and modified with folate (FA) targeting molecules.</p><p><strong>Results: </strong>The designed BP/single-atom nanoenzyme platform can target tumor tissues and generate substantial amounts of reactive oxygen species (ROS), demonstrating biocompatibility and improved catalytic activity.</p><p><strong>Conclusion: </strong>The nanoplatform effectively targets HCC and enhances PDT efficacy by increasing ROS production, offering a promising approach for HCC treatment.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"19 ","pages":"12583-12592"},"PeriodicalIF":6.6000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S414938","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Conventional treatments for hepatocellular carcinoma (HCC) lack efficacy and targeting abilities. Photodynamic therapy (PDT) has emerged as a promising alternative for targeted and minimally invasive tumor treatments. However, many biomaterials used in PDT pose biosafety concerns and insufficient enzyme activity often leads to limited reactive oxygen species (ROS) production, resulting in poor PDT efficacy. Single-atom nanoenzymes have attracted much research attention as a novel type of high-performance nanoenzymes.
Methods: In this study, we prepared black phosphorus nanosheets (BP) with good biocompatibility as a platform and loaded single-atom gold nanoenzymes onto BP nanosheets to treat HCC. To enhance the stability and targeting ability of the nanohybrid, it was PEGylated and modified with folate (FA) targeting molecules.
Results: The designed BP/single-atom nanoenzyme platform can target tumor tissues and generate substantial amounts of reactive oxygen species (ROS), demonstrating biocompatibility and improved catalytic activity.
Conclusion: The nanoplatform effectively targets HCC and enhances PDT efficacy by increasing ROS production, offering a promising approach for HCC treatment.
期刊介绍:
The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area.
With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field.
Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.